Irbesartan hydrochloride

This classification denotes an angiotensin ii receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3OGC31WUMZ. European Medicines Agency schedules Irbesartan hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29917. Irbesartan hydrochloride generally arises in the molecular formula C25H28N6O.CLH. The term 'irbesartan hydrochloride' is a European Medicines Agency European Public Assessment Report System designation. Most nations, for tariff and trade purposes, schedule irbesartan hydrochloride under HS 29332990 and SITC 51573. As of Q4 2014, IRBESARTAN HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CCCCC1=NC2(CCCC2)C(=O)N1CC3CCC(CC3)C4CCCCC4C5[NH]NNN5.CL.